IgG and IgM antiganglioside M1 antibodies in primary Sjogren's syndrome with and without peripheral neuropathy [1]

Clinical Rheumatology

Volumn 22, Issue 3, 2003, Pages 256-258

  Giordano, N ^a   Lucani, B ^a   Amendola, A ^a   Geraci, S ^a   Santacroce, C ^a   Gennari, C ^a   Hartini, G ^a   Nuti, R ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY SPECIFICITY; ANTIBODY TITER; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROMYOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; LABORATORY TEST; LETTER; MALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SENSORIMOTOR NEUROPATHY; SJOEGREN SYNDROME; STATISTICAL ANALYSIS;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; PROBABILITY; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SJOGREN'S SYNDROME;

EID: 0141893535     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0709-2     Document Type: Letter

References (16)

1. Yuki N, Miyatani N, Sato S, Hirabayashi Y et al. (1992) Acute relapsing sensory neuropathy associated with IgM antibodies against B-series gangliosides containing a GalNAc beta 1-4(Gal3-2 alpha NeuAc8-2 alpha NeuAc) beta 1 configuration. Neurology 42:686-689
2. Baumann N, Harpin ML, Marie Y, Lemerle K, Chassandre B, Bouche P et al. (1998) Antiglycolipid antibodies in motor neuropathies. Ann N Y Acad Sci 845:322-329
3. Salih AM, Nixon NB, Gargan RM, Heath P, Hawkins CP, Dawers PT (1996) Anti-ganglioside antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy. Br J Rheumatol 34:725-731
4. Hashimoto H (1999) Peripheral neuropathies in lupus patients with anti-GM1 antibodies. Intern Med 38:689-690
5. Galeazzi M, Annunziata P, Sebastiani GD, Bellisari F, Campanella V, Ferrara GB et al. (2000) Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerned Action on Immunogenetics of SLE. J Reumatol 27:135-141
6. Barendregt PJ, van den Bent MJ, van Raaij-van den Aarssen VJ, van den Meiracker AH, Vecht CJ, van der Heijde GL et al. (2001) Involvement of the peripheral nervous system in primary Sjogren'syndrome. Ann Rheum Dis 60:876-881
7. Zeballos RS, Fox RI, Cheresh DA, McPherson RA (1994) Anti-glycosphingolipid autoantibodies in rheumatologic disorders. J Clin Lab Anal 8:378-384
8. Bansal AS, Abdul-Karim B, Malik RA, Goulding P, Pumphrey RSH, Boulton AJM et al. (1994) IgM ganglioside GM1 anti-bodies in patients with autoimmune diseases or neuropathy, and controls. J Clin Pathol 47:300-302
9. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY et al. (1996) Assessment of classification criteria for Sjogren's syndrome: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome . Ann Rheum Dis 55:116-121
10. Asbury AK, New aspects of disease of the peripheral nervous system. Harrison's Textbook of Internal Medicine Update IV. New York: McGraw-Hill, 1983:211-229
11. Uetz-von Allmen E, Sturzenegger M, Rieben R, Rihs F, Frauenfelder A et al. (1998) Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls. Eur Neurol 39:103-110
12. Kornberg AJ (2000) Anti-GM1 ganglioside antibodies: their role in the diagnosis and pathogenesis of immune-mediated motor neuropathies. J Clin Neurosci 7:191-194
13. Gatterbauer B, Neisser A, Berheimer H, Schwerer B (1998) Antiglycosphingolipid immune responses in neurology. The Vienna experience with isotypes, subclasses and diseases. Ann NY Acad Sci 845:353-362
14. Claudie C, Vial C, Petiot P, Bancel J, Later R, Gonnaud PM (1999) Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies. Ann Biol Clinic 57:579-588
15. McCombe PA, Wilson R, Prentice RL (2000) Results of testing for anti-GM1 antibodies. J Clin Neurosci 7:209-212
16. Weller M, Stevens A, Sommer N, Dichgans J, Kappler B, Wietholter H (1992) Ganglioside antibodies: a lack of diagnostic specificity and clinical utility? J Neurol 239:455-459